Dedicated to Research Since 1993

Global Peptide Synthesis Market by Product (Reagents, Equipment) by Technology (Solid-Phase Peptide Synthesis (SPPS), Solution-Phase Synthesis (SPS), Hybrid and Recombinant Technology)– Business Overview, Analysis and Industry Forecast 2017-2023

 Healthcare and Pharmaceuticals

Report Overview

Global Peptide SynthesisMarket was valued at USD 327 Million in the year 2017. Global Peptide Synthesis Market is further estimated to grow at a CAGR of 6.27% from 2019 to reach USD 471 Million by the year 2023. The North America region holds the highest market share in 2017 and the Asia Pacific is considered as the fastest growing market in the forecasted period. At a country level, US, China, and the U.S. are projected to grow strongly in the coming years due to increasing density of population and funding through Research and Development.

Genscript Biotech (U.S), Merck KGaA (Germany), Aapptec (China) are the key players in this market. 


            Increasing Use of Peptides in Pharmaceutical Drugs 


            Lack of a unified set of regulations for therapeutic peptides 


            Emerging Market 


            Issues Associated With the Route of Administration of Peptide Drugs

The Global Peptide Synthesis Market is divided into By Product, Technology, End User and Region. Based on Product, peptide synthesis market has been segmented into reagents and equipment. The equipment segment has been sub-segmented into peptide synthesizers, chromatography equipment, and lyophilizers. This segment is expected to grow at the highest CAGR in the next five years. Technological innovations, automation, and advancements in instruments; replacement of older equipment with new ones; increasing demand from the Asian market; and growing demand for synthesized peptides, are factors driving the high growth of this market. By Technology, the peptide synthesis market has been segmented into solid-phase synthesis, liquid-phase synthesis, and hybrid & recombinant technology. Solid-phase synthesis held the largest share of the peptide synthesis market in 2017 due to advantages such as ease of operation, easy purification, short production cycles, high-level automation, and synthesis capabilities of long peptides in small quantities of amino acids.

By End User, the global peptide synthesis market is segmented into pharmaceutical and biotechnology companies, contract development and manufacturing organizations, and academic and research institutes. The contract development and manufacturing organizations segment is projected to grow at the highest CAGR in the peptide synthesis market. Increasing demand for cost-effective peptide synthesis services in drug development activities and life science research is a key driver for this end-user segment.

Key Benefits for Stakeholders

Biotechnology & pharmaceutical companies

Market research and consulting firms

Venture capitalists and investors

Research & development companies

Contract research organizations (CROs)

Academic research institutes

Government institutes

By Product



By Technology

Solid-Phase Peptide Synthesis (SPPS)

Solution-Phase Synthesis (SPS)

Hybrid and Recombinant Technology

By End User

Pharmaceutical and Biotechnology Companies

Contract Development and Manufacturing Organization

Academic and Research Institutes

By Region

North America




Key Market Players

Genscript Biotech

Merck KGaA 


Bachem Holdings

Anaspec (A Subsidiary of Kaneka Eurogentec S.A.) 


CEM Corporation

Gyros Protein Technologies

Advanced Chemtech 

NEP (New England Peptide)

(A brief overview of 10 companies is also provided)

Research Methodology:

Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –

  1.      Raw Market Data is collected and compared with the Existing in-house Data on a broad front.
  2.      Both Bottom-Up and Top-Down approaches are analyzed for segmenting and estimating measurable aspects of the market.
  3.      To avoid bias, we filter the collected data collected from authenticated sources.
  4.      GMI has a well proven Statistical Modeling System for estimates and forecasts.
  5.      Further, the report findings are validated with the Industry Expert Panel on face to face or telephonic interviews.
  6.      Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.

Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

       1.1.1 Market Definition

       1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

       2.1.1. Secondary Research

    Key Data from Secondary Research

       2.1.2. Primary Research

    Key Data from Primary Research

    Breakdowns of Primary Interviews

2.2. Market Size Estimation

       2.2.1. Bottom-Up Approach

       2.2.2. Top-Down Approach

       2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

       2.4.1. Assumption

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.7. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

       5.2.1. Threat of New Entrants

       5.2.2. Threat of Substitutes

       5.2.3. Bargaining Power of Buyers

       5.2.4. Bargaining Power of Suppliers

       5.2.5. Intensity of Competitive Rivalry

6. Global Peptide Synthesis Market, By Product

6.1 Reagents

6.2 Equipment

7. Global Peptide Synthesis Market, By Technology

7.1 Solid-Phase Peptide Synthesis (SPPS)

7.2 Solution-Phase Synthesis (SPS)

7.3 Hybrid and Recombinant Technology

8. Global Peptide Synthesis Market, By End User

8.1 Pharmaceutical and Biotechnology Companies

8.2 Contract Development and Manufacturing Organization

8.3 Academic and Research Institutes

9. Geographical Analysis

9.1. Introduction

9.2. North America

       9.2.1. U.S.

       9.2.2. Canada

       92.3. Mexico

9.3. Europe

       9.3.1. U.K.

       9.3.2. Germany

       9.3.3. Italy

       9.3.4. France

       9.3.5. RoE

9.4. Asia Pacific

       9.4.1. South Korea

       9.4.2. China

       9.4.3. Japan

       9.4.4. India

       9.4.5. RoAPAC

9.5. RoW

       9.5.1. Latin America

       9.5.2. Middle East and Africa

10. Company Profiles

10.1 Genscript Biotech

10.2 Merck KGaA 

10.3 Aapptec

10.4 Bachem Holdings

10.5 Anaspec (A Subsidiary of Kaneka Eurogentec S.A.) 

10.6 Biotage 

10.7 CEM Corporation

10.8 Gyros Protein Technologies

10.9 Advanced Cemtech 

10.9 NEP (New England Peptide)

 (A brief overview of 10 companies is also provided)

11. Competitive Analysis

11.1. Introduction

11.2. Market Positioning of Key Players

11.3 Competitive Strategies Adopted by Leading Players

        11.3.1. Investments & Expansions

        11.3.2. New Product Launches

        11.3.3. Mergers & Acquisitions

        11.3.4. Agreements, Joint Ventures, and Partnerships

12. Appendix

12.1. Questionnaire

12.2. Available Customizations 

12.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)


No Content Available.



Related Reports

Fatal error: Maximum execution time of 30 seconds exceeded in /home/genesismarketins/public_html/system/libraries/Session/drivers/Session_files_driver.php on line 263